CICC Capital Leads RMB1 Billion Round In Cancer Screening Firm

This Data Is Locked!

This area is available only to Subscribers.

Shanghai Singlera Genomics, a genetic early cancer screening company, has completed nearly RMB1 billion yuan in Series B financing. This round of financing was led... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?